Abstract |
Nonalcoholic fatty liver disease ( NAFLD) is considered as a liver manifestation of metabolic disorders. Previous studies indicate that the renin-angiotensin system (RAS) plays a complex role in NAFLD. As the only precursor of the RAS, decreased angiotensinogen (AGT) profoundly impacts RAS bioactivity. Here, we investigated the role of hepatocyte-derived AGT in liver steatosis. AGT floxed mice (hepAGT+/+) and hepatocyte-specific AGT-deficient mice (hepAGT-/-) were fed a Western diet and a normal laboratory diet for 12 weeks, respectively. Compared with hepAGT+/+ mice, Western diet-fed hepAGT-/- mice gained less body weight with improved insulin sensitivity. The attenuated severity of liver steatosis in hepAGT-/- mice was evidenced by histologic changes and reduced intrahepatic triglycerides. The abundance of SREBP1 and its downstream molecules, acetyl-CoA carboxylase and FASN, was suppressed in hepAGT-/- mice. Furthermore, serum derived from hepAGT+/+ mice stimulated hepatocyte SREBP1 expression, which could be diminished by protein kinase B (Akt)/ mammalian target of rapamycin (mTOR) inhibition in vitro. Administration of losartan did not affect diet-induced body weight gain, liver steatosis severity, and hepatic p-Akt, p-mTOR, and SREBP1 protein abundance in hepAGT+/+ mice. These data suggest that attenuation of Western diet-induced liver steatosis in hepAGT-/- mice is associated with the alternation of the Akt/mTOR/ SREBP-1c pathway.
|
Authors | Xin-Ran Tao, Jia-Bing Rong, Hong S Lu, Alan Daugherty, Peng Shi, Chang-Le Ke, Zhao-Cai Zhang, Yin-Chuan Xu, Jian-An Wang |
Journal | Journal of lipid research
(J Lipid Res)
Vol. 60
Issue 12
Pg. 1983-1995
(12 2019)
ISSN: 1539-7262 [Electronic] United States |
PMID | 31604805
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2019 Tao et al. Published by The American Society for Biochemistry and Molecular Biology, Inc. |
Chemical References |
- Fatty Acids
- Sterol Regulatory Element Binding Protein 1
- Angiotensinogen
- Proto-Oncogene Proteins c-akt
- TOR Serine-Threonine Kinases
|
Topics |
- Angiotensinogen
(deficiency, metabolism)
- Animals
- Diet, Western
(adverse effects)
- Fatty Acids
(metabolism)
- Hepatocytes
(drug effects, metabolism)
- Mice
- Non-alcoholic Fatty Liver Disease
(chemically induced, metabolism, pathology)
- Proto-Oncogene Proteins c-akt
(metabolism)
- Renin-Angiotensin System
(drug effects)
- Signal Transduction
(drug effects)
- Sterol Regulatory Element Binding Protein 1
(metabolism)
- TOR Serine-Threonine Kinases
(metabolism)
|